I just checked the last presentation I saw. It's from October 2019. It says that CVBT/Venturis had 4 patents & 27 pending. So in the last quarter they have added 3 patents & have an extra 4 pending. They are on fire. This is exactly what big pharma looks for blockbuster therapies with patent protection. In the email I got a few days ago announcing the new name they pointed out that AveXis & The Medicines Co each had 1 patent & were bought out by Novartis for a combined value of almost $18bn!! Incredible.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.